Synthetic BiologybioRxivPreprint
A Versatile Anti-CRISPR Platform for Opto- and Chemogenetic Control of CRISPR-Cas9 and Cas12 across a Wide Range of Orthologs
Luca Brenker, Sabine Aschenbrenner, Felix Bubeck…·Dominik Niopek
This paper develops a versatile platform for optogenetic and chemogenetic control of CRISPR-Cas9 and Cas12 across multiple orthologs using engineered anti-CRISPR proteins.
6 citations